Dana dhuwit perusahaan: abcellera.com (ABCL)

Logo grafis AbCellera Bio (ABCL)

The financial stability of AbCellera Biologics (ABCL) is constrained by the volatility of licensing revenues and the success of its partners. The cash balance history on GURU.Markets illustrates current liquidity, where the 0.79 metric reflects capital dynamics. AI algorithms and microfluidics create a technological moat that protects the business. Growth prospects are driven by the implementation of research software and long-term royalties from pharmaceutical behemoths.

Dana dhuwit perusahaan: AbCellera Biologics Inc. (ABCL) kanggo 04.07.2022 - 21.11.2026

Rincian metrik keuangan lan pasar abcellera.com (ABCL)

- indikator kapitalisasi bursa perusahaan:
Analisis komprehensif perusahaan:AbCellera Biologics Inc ABCL
Produk mawa merek AbCellera Biologics

The AbCellera Biologics (ABCL) business model is based on milestone payments for antibody development, rendering the company independent of macroeconomic cycles. By analyzing changes in cash and cash equivalents, an investor tracks the actual balance of liquid assets and the burn rate, which allows for an assessment of the organization's financial stability and its ability to sustain research until new royalties are received from pharmaceutical partners.

Pesaing langsung

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|Sisa dhuwit perusahaan TRML (Tourmaline Bio)|PGEN: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Pharming Group N.V. (PHAR)|Dana dhuwit perusahaan Nektar|upstreambio.com (UPB) - Aset likuid perusahaan|Dana dhuwit perusahaan Zenas Bio (ZBIO)|Aset likuid perusahaan Immunome Inc|Dana dhuwit perusahaan Gossamer Bio, Inc. GOSS|Volume dana dhuwit perusahaan KalVista Pharmaceuticals Inc KALV|SEPN - Dana dhuwit perusahaan|PVLA - Volume dana dhuwit perusahaan|SVRA: Volume dana dhuwit perusahaan|RIGL - Aset likuid perusahaan|ANAB (AnaptysBio Inc) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Astria Corp (ATXS)|Volume dana dhuwit perusahaan ENGN|Aset likuid perusahaan rapt.com|Volume dana dhuwit perusahaan JBIO (Aerovate Therapeutics Inc)|Aset likuid perusahaan Aclaris Therapeutics, Inc. (ACRS)|KYTX - Dana dhuwit perusahaan|Aset likuid perusahaan Tiziana Life Sciences TLSA|CABA: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan VTYX|Dhuwit awis perusahaan THTX|Volume dana dhuwit perusahaan Avalo Therapeutics Inc.|Dana dhuwit perusahaan Eledon (ELDN)|Volume dana dhuwit perusahaan Agenus Inc (AGEN)|Volume dana dhuwit perusahaan CLYM (climbbio.com)|ZURA - Dhuwit awis perusahaan|atyrpharma.com - Volume dana dhuwit perusahaan|ADAG (adagene.com) - Dhuwit awis lan setara dhuwit awis perusahaan|IMA (Ikena Oncology) - Dhuwit awis perusahaan|Dhuwit awis perusahaan Shattuck Labs Inc|EQ (Equillium Inc) - Volume dana dhuwit perusahaan|CNTB: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IMUX|ATRA (Atara Biotherapeutics, Inc.) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IFRX (inflarx.de)|X4 Pharmaceuticals - Dana dhuwit perusahaan|Adicet Bio, Inc. - Volume dana dhuwit perusahaan|CELU (celularity.com) - Dhuwit awis lan setara dhuwit awis perusahaan|INMB: Volume dana dhuwit perusahaan|Barinthus Biotherapeutics PLC (BRNS) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Kezar Life Sciences|Dhuwit awis perusahaan SAB Biotherapeutics (SABS)|Dana dhuwit perusahaan Akari Therapeutics Plc (AKTX)|Dhuwit awis perusahaan Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Dhuwit awis perusahaan|GeoVax Labs (GOVX) - Cadangan dhuwit perusahaan|edesabiotech.com - Volume dana dhuwit perusahaan|Aset likuid perusahaan iBio Corp IBIO|CARM: Volume dana dhuwit perusahaan|xtlbio.com (XTLB) - Volume dana dhuwit perusahaan|BOLT (Bolt Biotherapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan HCW Biologics (HCWB)|Dhuwit awis perusahaan APVO (Aptevo Therapeutics)|AIM - Cadangan dhuwit perusahaan|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD